Analysts’ Viewpoint
Demand for jet nebulizers is increasing across the globe due to rise in prevalence of respiratory disorders such as asthma, COPD, and cystic fibrosis. Technological advancements in healthcare devices, lucrative presence of international as well as regional players, and rising geriatric patients all over the world are contributing to the jet nebulizers market growth.
Similarly, environmental pollution, smoking, and changing lifestyles are contributing to the growing issues of respiration. Companies in the global jet nebulizers market should accelerate their product development to obtain competitive benefits. However, drug loss during delivery is likely to hamper growth opportunities of the global jet nebulizers market during the forecast period.
A pneumatic (jet) nebulizer is a device that converts liquid medication into a mist, which can then be inhaled through a mouthpiece or face mask. Jet nebulizers are often used to deliver medication to the respiratory system, including the bronchi and lungs. They are commonly used to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.
They work by using compressed air or oxygen to create a high-velocity stream of air that breaks up the liquid medication into small droplets, which can be inhaled. Jet nebulizers are typically used in a healthcare setting; however, they can also be used at home under the guidance of a healthcare provider.
Vented jet nebulizers and breath-actuated jet nebulizers are the two primary types of jet nebulizers.
Pneumatic nebulizer is the most widely used nebulizer due to its suitability for all types of medications. Moreover, it is easy to handle and less expensive as compared to other nebulizers (ultrasonic, mesh).
Chronic respiratory diseases include all medical conditions that affect the airways and other lung structures. Some common chronic respiratory diseases are asthma, chronic obstructive lung disease (COPD), including chronic obstructive pulmonary disease, bronchitis and emphysema, lung cancer, neoplasms of the respiratory tract, intrathoracic pulmonary heart disease, and diseases of pulmonary circulation.
According to the World Health Organization (WHO), in 2019, over 65 million people suffered from chronic obstructive pulmonary disease (COPD), and 3 million succumbed to it, making it the third-leading cause of death globally. Over 80% of these deaths occurred in low- and middle-income countries (LMIC).
Over 262 million people suffer from asthma ‒ the most common chronic pediatric disease that affects 14% of all children globally every year.
Rise in prevalence of such diseases and rapid introduction and the availability of jet nebulizer, cost-contained, and easy-to-use jet nebulizer for the treatment of such conditions drive the demand for jet nebulizers and consequently, are estimated to boost the jet nebulizers industry during the forecast period.
The immune system of a person weakens with age. Therefore, surge in geriatric population increases the probability of contracting diseases in this age group. The proportion of the world's population over 60 years is expected to double from 11% to 22% between 2000 and 2050. The number of people aged 60 and above is expected to increase from 605 million to 2.1 billion during the same period. Increasing age leads to higher risk of asthma and COPD. Therefore, management of asthma and COPD is crucial and problematic after 65 years of age.
People above 65 years of age diagnosed with asthma and COPD are unable to consume liquid medication. Thus, nebulizers are the preferred choice to administer medication, as these convert liquid medications into aerosol or mist. Jet nebulizers are an effective way to deliver medication to the lungs in a home healthcare setting, and can help improve the management of respiratory conditions.
Patients can easily inhale aerosol through a mouthpiece or facemask (connected to the nebulizer) without feeling uncomfortable. Therefore, increase in geriatric population is likely to boost the jet nebulizers market growth in the near future.
In 2021, the breath actuated jet nebulizer segment held the highest revenue share of more than 70%. This trend is expected to continue during the forecast period. Breath-actuated jet nebulizers have a higher drug delivery capacity and less dosage waste. Consequently, the segment that provides advanced inhalation therapy is expected to dominate the market during the forecast period. The affordability and ease of integration of breath actuated jet nebulizers have driven their popularity.
Based on end-user, the home healthcare segment is likely to expand significantly in the next few years, due to the increased use of jet nebulizers in the home setting during the COVID-19 pandemic. The use of jet nebulizers at home allows individuals to administer medication to themselves, which can help reduce the number of hospital visits and the spread of the virus. Additionally, increase in the number of cases of respiratory conditions, such as asthma and COPD, is estimated to fuel the demand for home healthcare services.
Moreover, growing geriatric population, increase in incidence of chronic diseases, and technological advancements in home healthcare devices are also anticipated to propel the segment during the forecast period.
According to the jet nebulizers industry analysis, North America accounted for the largest share of the global market in 2021, and the trend is projected to continue during the forecast period due to rise in prevalence of various respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. Some other factors fueling jet nebulizers market growth in the region are technological advancements in healthcare and increase in adoption of home healthcare facilities.
The jet nebulizer market forecast for Europe is highly positive. Demand for jet nebulizers in the region is anticipated to grow at a rapid pace during the forecast period owing to significant improvement in the healthcare system, high awareness about jet nebulizers, and increase in initiatives adopted by governments in the region in order to provide better health care services.
The future market value of jet nebulizers in Asia Pacific is projected to grow at a prominent CAGR during the forecast period. New product developments and technological advancements are expected to augment jet nebulizers market growth in the region during the forecast period.
Leading companies in the global jet nebulizers industry are Beurer GmbH, Besco Medical Co.,LTD, Bremed Ltd., Drive DeVilbiss Healthcare, GE HealthCare, Koninklijke Philips N.V., Morepen Laboratories Ltd., Nidek Medical Products Inc., OMRON Healthcare, Inc., PARI Respiratory Equipment, Inc., Rossmax International Ltd, SunMed, and VECTURA GROUP PLC. These companies are increasingly focusing on strategic acquisitions and partnerships to expand their product portfolio.
Prominent players have been profiled in the jet nebulizers market report based on parameters such as product portfolio, recent developments, financial overview, company overview, strategies, and segments.
| Attribute | Detail |
|---|---|
| Size in 2021 | US$ 648.0 Mn |
| Forecast (Value) in 2031 | More than US$ 1.3 Bn |
| Compound Annual Growth Rate (CAGR) | 7.3% |
| Forecast Period | 2022-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Mn/Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The global market was valued at US$ 648.0 Mn in 2021
It is projected to reach more than US$ 1.3 Bn by 2031
The CAGR is expected to be 7.3% from 2022 to 2031
Increase in prevalence of respiratory diseases and rise in geriatric population worldwide
Beurer GmbH, Besco Medical Co.,LTD, Bremed Ltd., Drive DeVilbiss Healthcare, GE HealthCare, Koninklijke Philips N.V., Morepen Laboratories Ltd., Nidek Medical Products Inc., OMRON Healthcare, Inc., PARI Respiratory Equipment, Inc., Rossmax International Ltd, SunMed , and VECTURA GROUP PLC.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Jet Nebulizers Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Jet Nebulizers Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Industry Events
5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Jet Nebulizers Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017-2031
6.3.1. Breath-actuated Nebulizer
6.3.2. Vented Nebulizer
6.4. Market Attractiveness Analysis, by Product Type
7. Global Jet Nebulizers Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Chronic Obstructive Pulmonary Disease (COPD)
7.3.2. Asthma
7.3.3. Cystic Fibrosis
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Jet Nebulizers Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals & Clinics
8.3.2. Home Healthcare Setting
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Jet Nebulizers Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Jet Nebulizers Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017-2031
10.2.1. Breath-actuated Nebulizer
10.2.2. Vented Nebulizer
10.3. Market Value Forecast, by Application, 2017-2031
10.3.1. Chronic Obstructive Pulmonary Disease (COPD)
10.3.2. Asthma
10.3.3. Cystic Fibrosis
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals & Clinics
10.4.2. Home Healthcare Setting
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Jet Nebulizers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2031
11.2.1. Breath-actuated Nebulizer
11.2.2. Vented Nebulizer
11.3. Market Value Forecast, by Application, 2017-2031
11.3.1. Chronic Obstructive Pulmonary Disease (COPD)
11.3.2. Asthma
11.3.3. Cystic Fibrosis
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals & Clinics
11.4.2. Home Healthcare Setting
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Jet Nebulizers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017-2031
12.2.1. Breath-actuated Nebulizer
12.2.2. Vented Nebulizer
12.3. Market Value Forecast, by Application, 2017-2031
12.3.1. Chronic Obstructive Pulmonary Disease (COPD)
12.3.2. Asthma
12.3.3. Cystic Fibrosis
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals & Clinics
12.4.2. Home Healthcare Setting
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Jet Nebulizers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017-2031
13.2.1. Breath-actuated Nebulizer
13.2.2. Vented Nebulizer
13.3. Market Value Forecast, by Application, 2017-2031
13.3.1. Chronic Obstructive Pulmonary Disease (COPD)
13.3.2. Asthma
13.3.3. Cystic Fibrosis
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals & Clinics
13.4.2. Home Healthcare Setting
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Jet Nebulizers Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017-2031
14.2.1. Breath-actuated Nebulizer
14.2.2. Vented Nebulizer
14.3. Market Value Forecast, by Application, 2017-2031
14.3.1. Chronic Obstructive Pulmonary Disease (COPD)
14.3.2. Asthma
14.3.3. Cystic Fibrosis
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals & Clinics
14.4.2. Home Healthcare Setting
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2021)
15.3. Company Profiles
15.3.1. Beurer GmbH
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Besco Medical Co.,LTD
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Bremed Ltd.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. Drive DeVilbiss Healthcare
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. GE HealthCare
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Koninklijke Philips N.V.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Morepen Laboratories Ltd.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Nidek Medical Products Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. OMRON Healthcare, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. PARI Respiratory Equipment, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
15.3.11. Rossmax International Ltd
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Strategic Overview
15.3.12. SunMed
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Strategic Overview
15.3.13. VECTURA GROUP PLC
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Strategic Overview
List of Tables
Table 01: Global Jet Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global Jet Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 03: Global Jet Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 04: Global Jet Nebulizers Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 05: North America Jet Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 06: North America Jet Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 07: North America Jet Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 08: North America Jet Nebulizers Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 09: Europe Jet Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 10: Europe Jet Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 11: Europe Jet Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 12: Europe Jet Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 13: Asia Pacific Jet Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 14: Asia Pacific Jet Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 15: Asia Pacific Jet Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Asia Pacific Jet Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Latin America Jet Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 18: Latin America Jet Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 19: Latin America Jet Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 20: Latin America Jet Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 21: Middle East & Africa Jet Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 22: Middle East & Africa Jet Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 23: Middle East & Africa Jet Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 24: Middle East & Africa Jet Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
List of Figures
Figure 01: Global Jet Nebulizers Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Jet Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 03: Global Jet Nebulizers Market Attractiveness Analysis, by Product Type, 2017-2031
Figure 04: Global Jet Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031
Figure 05: Global Jet Nebulizers Market Attractiveness Analysis, by Application, 2017-2031
Figure 06: Global Jet Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 07: Global Jet Nebulizers Market Attractiveness Analysis, by End-user, 2017-2031
Figure 08: Global Jet Nebulizers Market Analysis and Forecast, by Region, 2021 and 2031
Figure 09: Global Jet Nebulizers Market Attractiveness Analysis, by Region, 2017-2031
Figure 10: North America Jet Nebulizers Market Value (US$ Mn) Forecast, 2017-2031
Figure 11: North America Jet Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 12: North America Jet Nebulizers Market Attractiveness Analysis, by Product Type, 2017-2031
Figure 13: North America Jet Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031
Figure 14: North America Jet Nebulizers Market Attractiveness Analysis, by Application, 2017-2031
Figure 15: North America Jet Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 16: North America Jet Nebulizers Market Attractiveness Analysis, by End-user, 2017-2031
Figure 17: North America Jet Nebulizers Market Analysis and Forecast, by Country, 2021 and 2031
Figure 18: North America Jet Nebulizers Market Attractiveness Analysis, by Country, 2017-2031
Figure 19: Europe Jet Nebulizers Market Value (US$ Mn) Forecast, 2017-2031
Figure 20: Europe Jet Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 21: Europe Jet Nebulizers Market Attractiveness Analysis, by Product Type, 2017-2031
Figure 22: Europe Jet Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031
Figure 23: Europe Jet Nebulizers Market Attractiveness Analysis, by Application, 2017-2031
Figure 24: Europe Jet Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 25: Europe Jet Nebulizers Market Attractiveness Analysis, by End-user, 2017-2031
Figure 26: Europe Jet Nebulizers Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 27: Europe Jet Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
Figure 28: Asia Pacific Jet Nebulizers Market Value (US$ Mn) Forecast, 2017-2031
Figure 29: Asia Pacific Jet Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 30: Asia Pacific Jet Nebulizers Market Attractiveness Analysis, by Product Type, 2017-2031
Figure 31: Asia Pacific Jet Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031
Figure 32: Asia Pacific Jet Nebulizers Market Attractiveness Analysis, by Application, 2017-2031
Figure 33: Asia Pacific Jet Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 34: Asia Pacific Jet Nebulizers Market Attractiveness Analysis, by End-user, 2017-2031
Figure 35: Asia Pacific Jet Nebulizers Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 36: Asia Pacific Jet Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
Figure 37: Latin America Jet Nebulizers Market Value (US$ Mn) Forecast, 2017-2031
Figure 38: Latin America Jet Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 39: Latin America Jet Nebulizers Market Attractiveness Analysis, by Product Type, 2017-2031
Figure 40: Latin America Jet Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031
Figure 41: Latin America Jet Nebulizers Market Attractiveness Analysis, by Application, 2017-2031
Figure 42: Latin America Jet Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 43: Latin America Jet Nebulizers Market Attractiveness Analysis, by End-user, 2017-2031
Figure 44: Latin America Jet Nebulizers Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 45: Latin America Jet Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
Figure 46: Middle East & Africa Jet Nebulizers Market Value (US$ Mn) Forecast, 2017-2031
Figure 47: Middle East & Africa Jet Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 48: Middle East & Africa Jet Nebulizers Market Attractiveness Analysis, by Product Type, 2017-2031
Figure 49: Middle East & Africa Jet Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031
Figure 50: Middle East & Africa Jet Nebulizers Market Attractiveness Analysis, by Application, 2017-2031
Figure 51: Middle East & Africa Jet Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 52: Middle East & Africa Jet Nebulizers Market Attractiveness Analysis, by End-user, 2017-2031
Figure 53: Middle East & Africa Jet Nebulizers Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 54: Middle East & Africa Jet Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
Figure 55: Global Jet Nebulizers Market Share Analysis/Ranking, by Company, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Jet Nebulizers Market
